Calian Group (TSE:CGY) Given New C$76.00 Price Target at Canadian Imperial Bank of Commerce

Calian Group (TSE:CGY) had its price objective boosted by Canadian Imperial Bank of Commerce from C$65.00 to C$76.00 in a report issued on Friday morning,BayStreet.CA reports.

Several other brokerages have also recently issued reports on CGY. Ventum Financial upped their price objective on Calian Group from C$62.00 to C$72.00 and gave the company a “buy” rating in a research note on Tuesday, January 27th. Royal Bank Of Canada boosted their price target on Calian Group from C$58.00 to C$66.00 and gave the company an “outperform” rating in a report on Thursday, November 27th. Desjardins upped their price target on Calian Group from C$59.00 to C$66.00 and gave the company a “buy” rating in a research report on Thursday, November 27th. Finally, Canaccord Genuity Group raised their price objective on Calian Group from C$60.00 to C$63.00 and gave the stock a “buy” rating in a research note on Thursday, November 27th. Six equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of C$74.83.

Calian Group Price Performance

Shares of CGY stock opened at C$70.60 on Friday. The firm has a market cap of C$805.62 million, a P/E ratio of 40.11, a P/E/G ratio of 2.50 and a beta of 0.70. The company has a debt-to-equity ratio of 39.54, a current ratio of 1.29 and a quick ratio of 1.20. Calian Group has a 1-year low of C$37.70 and a 1-year high of C$71.92. The firm has a fifty day moving average of C$60.38 and a two-hundred day moving average of C$54.12.

Calian Group (TSE:CGY) last issued its earnings results on Thursday, February 12th. The company reported C$1.03 earnings per share (EPS) for the quarter. Calian Group had a net margin of 1.50% and a return on equity of 3.37%. The business had revenue of C$208.00 million for the quarter. As a group, research analysts anticipate that Calian Group will post 4.9475219 earnings per share for the current fiscal year.

Calian Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 11th. Stockholders of record on Wednesday, March 11th will be given a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.6%. The ex-dividend date is Wednesday, February 25th. Calian Group’s dividend payout ratio is presently 63.64%.

Trending Headlines about Calian Group

Here are the key news stories impacting Calian Group this week:

• Positive Sentiment: Record Q1 results — Calian reported C$208M revenue (up ~12% YoY) with margin gains and C$1.03 EPS, and management signaled confident growth on the earnings call; this strengthens the growth narrative driving buying interest. Calian Delivers Record Q1 Revenue and Margin Gains
• Positive Sentiment: Multiple analyst target upgrades — Acumen (to C$85, Buy), Canaccord (to C$80), CIBC (to C$76) and Ventum (to C$82, Buy) raised price targets, signaling broad analyst optimism and providing upward catalyst for the stock. Analyst Ratings Roundup
• Positive Sentiment: Quarterly dividend declared — Board approved a C$0.28 quarterly dividend (annualized yield ~1.6%), with ex-dividend Feb 25 and record Mar 11; supports shareholder return profile and can attract income-minded buyers.
• Neutral Sentiment: Corporate governance update — Shareholders re‑elected the board and named Valerie Sorbie as Chair, which preserves leadership continuity but is unlikely to move the stock materially by itself. Shareholder Meeting Results
• Negative Sentiment: RBC’s moderate target bump to C$60 — Although RBC maintained an “outperform” stance, its target remains well below the current price, indicating at least one major analyst sees less upside and creating potential resistance or caution among some investors. RBC Target Update

About Calian Group

Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.